Norstella announced the appointment of Kris Joshi as its new Chief Executive Officer, succeeding Mike Gallup, who will transition to the role of Executive Chairman. Norstella, through its brands Citeline, Evaluate, MMIT, Panalgo, and The Dedham Group, provides pharma intelligence solutions to support biopharma companies across the drug development and commercialization lifecycle. The company also offers its integrated data platform, NorstellaLinQ, which connects insights to help accelerate innovation in life sciences. Reflecting on his appointment, Joshi said, “What drew me to Norstella is its bold mission, exceptional team and commitment to harnessing AI to reshape the future of life sciences clinical development and commercialization. We have the opportunity to help our customers significantly accelerate innovation in the life sciences industry and improve access to groundbreaking therapies for patients by connecting insights across the value chain—and Norstella is uniquely positioned to lead that transformation.”
Joshi brings more than two decades of leadership experience across healthcare and technology. He most recently served as CEO of Optum’s $3 billion Software, Network, and Data business, and previously held senior roles at Change Healthcare, Oracle, IBM, and McKinsey & Company. Outgoing CEO Gallup said, “I can’t think of a more fitting CEO for this next phase of Norstella’s growth. Kris brings sharp insight and a deep understanding of data to the table. And most importantly, he believes in this mission and the company that we’ve built.” Board member Fred Hassan added, “We’re thrilled to welcome Kris, a truly purpose-driven leader who is eager to make a lasting, positive impact on healthcare and patient lives.”